A great proportion of the credit for the exponential growth of Al Andalous can be attributed to its Research and development department. Our R&D department is committed to producing superior generic versions of brand-name medicines to meet Egyptian and export requirements. To achieve this goal, our team’s dedication to quality is uncompromising. As great products start with great minds, R&D team comprises a group of highly trained pharmacists in research and development activities including pharmaceutical development, analytical method development and validation, stability studies and comparative dissolution and bioequivalence department. From working with raw materials with only the finest specifications to performing experiments using the latest scientific approaches, R&D team ensures the production of safe and effective pharmaceuticals with a premium quality.
Our Quality is further supported by good resource allocation. Al Andalous continues to provide R&D labs with cutting-edge instruments and state-of-the-art technologies. Furthermore, our scientists have access to the frontiers of pharmaceutical science in order to respond to current and future challenges in dosage form design. Armed with these resources, pharmaceutical researchers develop a vast range of dosage forms extending beyond the conventional ones. These include more innovative dosage forms which are difficult-to-formulate and difficult-to-manufacture like microemulsions, dry powder inhalers and nanocrystal formulations. Thus, a broader range of affordable drugs are produced to address unmet patient needs.
R&D is continuously optimizing their products to align with both national and worldwide standards. Alandalous R&D team is helping their company not only carve out their own niche in the Egyptian Pharmaceutical Industry, but also gain ground in exporting their products to new markets.